Structural Biophysics Group, School of Optometry and Vision Sciences, Cardiff University, Cardiff, UK.
Ophthalmic Physiol Opt. 2013 Mar;33(2):78-93. doi: 10.1111/opo.12032.
To review cross-linking the cornea using riboflavin and ultraviolet A light, which has been widely adopted, refined and applied in a range of corneal surgeries and pathologies where the strength of the cornea might be compromised.
A large number of clinical trials have been carried out, most of which have demonstrated that standard cross-linking is a successful method to halt the progression of keratoconus or even aid regression.
This review describes our current understanding of the technique, focussing on how cross-linking works, how the treatment is being optimised, the clinical results that have been reported to date and the potential use of the therapy in the treatment of other corneal disorders.
综述使用核黄素和紫外线 A 光进行角膜交联,该方法已被广泛应用于各种角膜手术和病变中,这些手术和病变可能会影响角膜的强度。
已经进行了大量的临床试验,其中大多数临床试验表明标准交联是一种成功的方法,可以阻止圆锥角膜的进展,甚至有助于其逆转。
本文综述了我们目前对该技术的理解,重点介绍了交联的作用方式、如何优化治疗、迄今为止报道的临床结果以及该疗法在治疗其他角膜疾病中的潜在用途。